Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

NEUROENDOCRINE CARCINOMA side effect

What is NEUROENDOCRINE CARCINOMA ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with NEUROENDOCRINE CARCINOMA

BETASERON  CISAPRIDE  FOLLITROPIN  SANDIMMUNE  


NEUROENDOCRINE CARCINOMA : Cisapride Side Effects Report #5411054-8
Physician from UNITED STATES reported CISAPRIDE problem on July 31, 2007. Female patient, weighting 114.0 lb, was diagnosed with gastrointestinal motility disorder, gastrooesophageal reflux disease, routine health maintenance, hypothyroidism, catheterisation venous, osteoporosis, iron deficiency, dyspepsia and was treated with CISAPRIDE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, neuroendocrine carcinoma, staphylococcal sepsis, urinary tract infection, . CISAPRIDE dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, COUMADIN, MIACALCIN, FERROUS SULPHATE, NEXIUM. Patient was hospitalized. Patient died.

NEUROENDOCRINE CARCINOMA : Betaseron Side Effects Report #5401894-3
BETASERON problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 56 years of age, weighting 160.9 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: depression, neuroendocrine carcinoma, pancreatic neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with PANCREASE MT, EFFEXOR, CLONAZEPAM, HYDROCHLOROTHIAZIDE, FERROUS SULPHATE, SYNTHROID, LAMICTAL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

NEUROENDOCRINE CARCINOMA : Betaseron Side Effects Report #5401894-3
Physician from UNITED STATES reported BETASERON problem on July 18, 2007. Female patient, 56 years of age, weighting 160.9 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: depression, neuroendocrine carcinoma, pancreatic neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with PANCREASE MT, EFFEXOR, CLONAZEPAM, HYDROCHLOROTHIAZIDE, FERROUS SULPHATE, SYNTHROID, LAMICTAL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

NEUROENDOCRINE CARCINOMA : Follitropin Side Effects Report #5421619-5
FOLLITROPIN BETA problem was reported by a Consumer or non-health professional from ITALY on Aug 13, 2007. Female patient, 36 years of age, was treated with FOLLITROPIN BETA. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma pancreas, liver disorder, neuroendocrine carcinoma, pancreatic carcinoma, . FOLLITROPIN BETA dosage: unknown. During the same period patient was treated with CHRORIONIC GONADOTROPHIN, PROGESTERONE. Patient died.

NEUROENDOCRINE CARCINOMA : Sandimmune Side Effects Report #5389451-9
Physician from GERMANY reported SANDIMMUNE problem on July 12, 2007. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, neuroendocrine carcinoma, rash, ultrasound liver abnormal, . SANDIMMUNE dosage: 200 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 04/23/2007.

NEUROENDOCRINE CARCINOMA : Sandimmune Side Effects Report #5389738-X
SANDIMMUNE problem was reported by a Physician from GERMANY on July 12, 2007. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, neuroendocrine carcinoma, rash, ultrasound liver abnormal, . SANDIMMUNE dosage: 200 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 04/23/2007.

NEUROENDOCRINE CARCINOMA : Sandimmune Side Effects Report #5389451-9
Physician from GERMANY reported SANDIMMUNE problem on July 12, 2007. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, neuroendocrine carcinoma, rash, ultrasound liver abnormal, . SANDIMMUNE dosage: 200 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 04/23/2007.

NEUROENDOCRINE CARCINOMA : Sandimmune Side Effects Report #5389738-X
SANDIMMUNE problem was reported by a Physician from GERMANY on July 12, 2007. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, neuroendocrine carcinoma, rash, ultrasound liver abnormal, . SANDIMMUNE dosage: 200 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 04/23/2007.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about NEUROENDOCRINE CARCINOMA side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about NEUROENDOCRINE CARCINOMA